A recent study indicates that individuals who come off popular GLP-1 drugs like Wegovy and Mounjaro tend to recover lost weight far faster than those who stop conventional diet and exercise programs.
Published data in a leading medical journal shows that while overweight individuals frequently drop a large proportion of their total mass while on the medication, the mass is regained at an estimated rate of nearly a kilo each month after stopping.
"People purchasing these drugs should be informed of the danger of quick weight regain when the therapy ends," stated lead investigator Dr. Susan Jebb.
That rate of recovery implies a return to starting mass within about one and a half years.
Analyzing Approaches
The research, which looked at dozens of studies involving over 9,000 of patients, compared the effects of the injectable medications with other pills.
Scientists point out that people who shed pounds through diet and exercise usually have a slower weight regain—approximately 100 grams monthly—once they finish.
The Reason for the Quick Regain
Doctors propose the mode of action of the drugs explains the accelerated rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing the hormone levels several times higher than the body's typical production might result in the body to produce less of its endogenous GLP-1, and could reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this hormone supplement leads to appetite is unsuppressed, making binge eating a significant risk."
An Ongoing Issue?
Health authorities advise the injections for individuals with weight-linked health risks, alongside prescribed lifestyle changes.
A number of clinicians say that, considering the likelihood of weight regain, the treatment might need to be ongoing.
This perspective is reinforced by drug manufacturers, who state that the results "highlight the chronic nature of excess weight," comparing it to managing diseases like high blood pressure.
Patient Accounts
People who have discontinued the medication describe a powerful return of hunger.
"It was like a switch flipping and you become ravenous," described one woman.
This difficulty is worsened if users have not established sustainable lifestyle or habit modifications during therapy.
Significant Interest
Figures suggest that millions of adults in the UK have used these injections in the last 12 months, with desire remaining high.
- Adoption is greater among females than men.
- The middle-aged age group shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
Finally, researchers caution that while GLP-1 drugs are potent agents for shedding pounds, they are not a permanent solution and lasting health benefits hinges on combined lifestyle management.
